HUB Investment Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4K Sell
300
-100
-25% -$4.3K ﹤0.01% 1372
2026
Q1
$14.7K Sell
400
-200
-33% -$9.48K ﹤0.01% 1139
2025
Q4
$30.5K Hold
600
﹤0.01% 943
2025
Q3
$33.3K Sell
600
-100
-14% -$5.85K ﹤0.01% 789
2025
Q2
$48.3K Sell
700
-1,500
-68% -$102K ﹤0.01% 701
2025
Q1
$153K Sell
2,200
-100
-4% -$8.26K 0.01% 565
2024
Q4
$58K Buy
2,300
+500
+28% +$54.1K ﹤0.01% 561
2024
Q3
$92.8K Buy
1,800
+1,100
+157% +$147K ﹤0.01% 510
2024
Q2
$93.5K Sell
700
-500
-42% -$66.3K ﹤0.01% 475
2024
Q1
$154K Buy
+1,200
New +$143K 0.01% 446

Other funds holding NVO

HUB Investment Partners's NVO Position: Q2 2026 in Review

HUB Investment Partners increased its Novo Nordisk (NVO) stake by 44% in Q2 2026, buying an estimated $195K and bringing the position to 14,756 shares worth $707K. The position accounts for 0.01% of the portfolio, ranked #567.

HUB Investment Partners first reported a position in NVO in Q4 2021 and has held it in 16 quarters since. The position peaked at $7.94M in Q2 2024. 697 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • HUB Investment Partners held 14,756 shares of Novo Nordisk worth $707K as of Q2 2026.
  • HUB Investment Partners bought 4,530 Novo Nordisk shares in Q2 2026, an estimated $195K.
  • Novo Nordisk made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #567 holding.
  • HUB Investment Partners first reported a position in Novo Nordisk in Q4 2021 and has held it in 16 quarters since.
  • HUB Investment Partners's Novo Nordisk position peaked at $7.94M in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.